Status:
COMPLETED
Intermittent Theta Burst Stimulation (iTBS) for the Treatment of Negative Symptoms in Schizophrenia
Lead Sponsor:
Hôpital le Vinatier
Conditions:
Schizophrenia
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether the iTBS is an effective treatment of the negative symptoms of schizophrenia.
Detailed Description
This study will evaluate whether the intermittent Theta Burst Stimulation (iTBS), a new high frequency TMS protocol is efficient in the treatment of the Negative Symptoms of schizophrenia. Neuroimagi...
Eligibility Criteria
Inclusion
- Schizophrenia according to DSM-IV
- Negative symptoms for at least 6 weeks
- Medication resistance according to Kane et al., 1988
- Age between 18 and 50 years old
- Informed consent
Exclusion
- Contraindication to TMS
- Pregnancy
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00875498
Start Date
November 1 2008
End Date
July 1 2015
Last Update
January 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Le vinatier
Bron, France